nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—colon cancer	0.543	1	CbGaD
Etravirine—CYP2C9—Capecitabine—colon cancer	0.0654	0.27	CbGbCtD
Etravirine—ABCB4—bile—colon cancer	0.0478	0.557	CbGeAlD
Etravirine—ABCB1—Irinotecan—colon cancer	0.0392	0.162	CbGbCtD
Etravirine—CYP2C9—Fluorouracil—colon cancer	0.0388	0.16	CbGbCtD
Etravirine—ABCB1—Vincristine—colon cancer	0.0343	0.141	CbGbCtD
Etravirine—CYP3A4—Irinotecan—colon cancer	0.0235	0.0969	CbGbCtD
Etravirine—ABCB1—Methotrexate—colon cancer	0.0208	0.0856	CbGbCtD
Etravirine—CYP3A4—Vincristine—colon cancer	0.0205	0.0847	CbGbCtD
Etravirine—ABCB4—gall bladder—colon cancer	0.0133	0.155	CbGeAlD
Etravirine—ABCB4—vagina—colon cancer	0.00461	0.0537	CbGeAlD
Etravirine—ABCB4—liver—colon cancer	0.00389	0.0453	CbGeAlD
Etravirine—ABCB4—lymph node—colon cancer	0.00298	0.0348	CbGeAlD
Etravirine—Rilpivirine—ABCB1—colon cancer	0.00254	1	CrCbGaD
Etravirine—ABCB1—blood vessel—colon cancer	0.00139	0.0162	CbGeAlD
Etravirine—CYP2C19—digestive system—colon cancer	0.00123	0.0144	CbGeAlD
Etravirine—CYP2C19—vagina—colon cancer	0.00109	0.0127	CbGeAlD
Etravirine—CYP2C9—digestive system—colon cancer	0.000955	0.0111	CbGeAlD
Etravirine—CYP2C19—liver—colon cancer	0.000918	0.0107	CbGeAlD
Etravirine—CYP3A4—renal system—colon cancer	0.000888	0.0104	CbGeAlD
Etravirine—ABCB1—embryo—colon cancer	0.00083	0.00968	CbGeAlD
Etravirine—CYP3A4—digestive system—colon cancer	0.000728	0.00849	CbGeAlD
Etravirine—CYP2C9—liver—colon cancer	0.000712	0.00829	CbGeAlD
Etravirine—ABCB1—epithelium—colon cancer	0.000678	0.0079	CbGeAlD
Etravirine—ABCB1—renal system—colon cancer	0.000629	0.00733	CbGeAlD
Etravirine—Acute coronary syndrome—Irinotecan—colon cancer	0.00062	0.00492	CcSEcCtD
Etravirine—Renal failure—Irinotecan—colon cancer	0.000619	0.0049	CcSEcCtD
Etravirine—Myocardial infarction—Irinotecan—colon cancer	0.000617	0.00489	CcSEcCtD
Etravirine—Stomatitis—Irinotecan—colon cancer	0.000614	0.00486	CcSEcCtD
Etravirine—Hepatic failure—Capecitabine—colon cancer	0.000608	0.00482	CcSEcCtD
Etravirine—Haemolytic anaemia—Capecitabine—colon cancer	0.000606	0.0048	CcSEcCtD
Etravirine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000594	0.00471	CcSEcCtD
Etravirine—Renal failure acute—Capecitabine—colon cancer	0.000592	0.00469	CcSEcCtD
Etravirine—Myocardial infarction—Fluorouracil—colon cancer	0.000591	0.00468	CcSEcCtD
Etravirine—Neuropathy peripheral—Fluorouracil—colon cancer	0.000591	0.00468	CcSEcCtD
Etravirine—Stomatitis—Fluorouracil—colon cancer	0.000588	0.00466	CcSEcCtD
Etravirine—Conjunctivitis—Fluorouracil—colon cancer	0.000586	0.00464	CcSEcCtD
Etravirine—Amnesia—Capecitabine—colon cancer	0.000582	0.00461	CcSEcCtD
Etravirine—Inflammation—Methotrexate—colon cancer	0.000578	0.00458	CcSEcCtD
Etravirine—Hypoaesthesia—Vincristine—colon cancer	0.000577	0.00457	CcSEcCtD
Etravirine—Atrial fibrillation—Capecitabine—colon cancer	0.000577	0.00457	CcSEcCtD
Etravirine—Urinary tract disorder—Vincristine—colon cancer	0.000573	0.00454	CcSEcCtD
Etravirine—Dermatitis bullous—Capecitabine—colon cancer	0.000572	0.00453	CcSEcCtD
Etravirine—Connective tissue disorder—Vincristine—colon cancer	0.00057	0.00452	CcSEcCtD
Etravirine—Urethral disorder—Vincristine—colon cancer	0.000569	0.00451	CcSEcCtD
Etravirine—Connective tissue disorder—Irinotecan—colon cancer	0.000555	0.0044	CcSEcCtD
Etravirine—CYP3A4—liver—colon cancer	0.000543	0.00632	CbGeAlD
Etravirine—Cardiac disorder—Vincristine—colon cancer	0.000538	0.00427	CcSEcCtD
Etravirine—Hypoaesthesia—Fluorouracil—colon cancer	0.000538	0.00427	CcSEcCtD
Etravirine—Angiopathy—Vincristine—colon cancer	0.000526	0.00417	CcSEcCtD
Etravirine—Cardiac disorder—Irinotecan—colon cancer	0.000524	0.00415	CcSEcCtD
Etravirine—Mediastinal disorder—Vincristine—colon cancer	0.000523	0.00414	CcSEcCtD
Etravirine—ABCB1—lymphoid tissue—colon cancer	0.000522	0.00608	CbGeAlD
Etravirine—ABCB1—digestive system—colon cancer	0.000516	0.00601	CbGeAlD
Etravirine—Angiopathy—Irinotecan—colon cancer	0.000513	0.00406	CcSEcCtD
Etravirine—Immune system disorder—Irinotecan—colon cancer	0.00051	0.00404	CcSEcCtD
Etravirine—Mediastinal disorder—Irinotecan—colon cancer	0.000509	0.00403	CcSEcCtD
Etravirine—Mental disorder—Vincristine—colon cancer	0.000508	0.00403	CcSEcCtD
Etravirine—Gynaecomastia—Methotrexate—colon cancer	0.000502	0.00397	CcSEcCtD
Etravirine—Dry skin—Capecitabine—colon cancer	0.000501	0.00397	CcSEcCtD
Etravirine—Breast disorder—Capecitabine—colon cancer	0.000494	0.00391	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000492	0.0039	CcSEcCtD
Etravirine—Flatulence—Irinotecan—colon cancer	0.000485	0.00384	CcSEcCtD
Etravirine—Gastritis—Capecitabine—colon cancer	0.000484	0.00383	CcSEcCtD
Etravirine—Abdominal distension—Capecitabine—colon cancer	0.000476	0.00377	CcSEcCtD
Etravirine—ABCB1—bone marrow—colon cancer	0.000475	0.00554	CbGeAlD
Etravirine—Diabetes mellitus—Methotrexate—colon cancer	0.000468	0.00371	CcSEcCtD
Etravirine—Anaemia—Vincristine—colon cancer	0.000467	0.0037	CcSEcCtD
Etravirine—Bronchospasm—Capecitabine—colon cancer	0.000465	0.00368	CcSEcCtD
Etravirine—Angina pectoris—Capecitabine—colon cancer	0.00046	0.00365	CcSEcCtD
Etravirine—Ill-defined disorder—Irinotecan—colon cancer	0.000456	0.00362	CcSEcCtD
Etravirine—ABCB1—vagina—colon cancer	0.000455	0.00531	CbGeAlD
Etravirine—Anaemia—Irinotecan—colon cancer	0.000455	0.0036	CcSEcCtD
Etravirine—Vertigo—Vincristine—colon cancer	0.000454	0.0036	CcSEcCtD
Etravirine—Hepatic failure—Methotrexate—colon cancer	0.000453	0.00359	CcSEcCtD
Etravirine—Vision blurred—Fluorouracil—colon cancer	0.000444	0.00352	CcSEcCtD
Etravirine—Malaise—Irinotecan—colon cancer	0.000444	0.00351	CcSEcCtD
Etravirine—Vertigo—Irinotecan—colon cancer	0.000442	0.0035	CcSEcCtD
Etravirine—Syncope—Irinotecan—colon cancer	0.000441	0.00349	CcSEcCtD
Etravirine—Renal failure acute—Methotrexate—colon cancer	0.000441	0.00349	CcSEcCtD
Etravirine—Convulsion—Vincristine—colon cancer	0.000438	0.00347	CcSEcCtD
Etravirine—Hypertension—Vincristine—colon cancer	0.000436	0.00345	CcSEcCtD
Etravirine—Anaemia—Fluorouracil—colon cancer	0.000435	0.00345	CcSEcCtD
Etravirine—Loss of consciousness—Irinotecan—colon cancer	0.000432	0.00343	CcSEcCtD
Etravirine—Hyperglycaemia—Capecitabine—colon cancer	0.000426	0.00338	CcSEcCtD
Etravirine—Hypertension—Irinotecan—colon cancer	0.000425	0.00336	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000418	0.00331	CcSEcCtD
Etravirine—Acute coronary syndrome—Capecitabine—colon cancer	0.000415	0.00329	CcSEcCtD
Etravirine—Renal failure—Capecitabine—colon cancer	0.000414	0.00328	CcSEcCtD
Etravirine—Discomfort—Irinotecan—colon cancer	0.000414	0.00328	CcSEcCtD
Etravirine—Neuropathy peripheral—Capecitabine—colon cancer	0.000413	0.00327	CcSEcCtD
Etravirine—Myocardial infarction—Capecitabine—colon cancer	0.000413	0.00327	CcSEcCtD
Etravirine—Stomatitis—Capecitabine—colon cancer	0.000411	0.00325	CcSEcCtD
Etravirine—Infection—Vincristine—colon cancer	0.00041	0.00324	CcSEcCtD
Etravirine—Conjunctivitis—Capecitabine—colon cancer	0.000409	0.00324	CcSEcCtD
Etravirine—Convulsion—Fluorouracil—colon cancer	0.000408	0.00323	CcSEcCtD
Etravirine—Confusional state—Irinotecan—colon cancer	0.000405	0.00321	CcSEcCtD
Etravirine—Nervous system disorder—Vincristine—colon cancer	0.000404	0.0032	CcSEcCtD
Etravirine—Thrombocytopenia—Vincristine—colon cancer	0.000404	0.0032	CcSEcCtD
Etravirine—Infection—Irinotecan—colon cancer	0.000399	0.00316	CcSEcCtD
Etravirine—Hyperhidrosis—Vincristine—colon cancer	0.000398	0.00316	CcSEcCtD
Etravirine—Hepatobiliary disease—Capecitabine—colon cancer	0.000398	0.00316	CcSEcCtD
Etravirine—Discomfort—Fluorouracil—colon cancer	0.000396	0.00314	CcSEcCtD
Etravirine—Shock—Irinotecan—colon cancer	0.000395	0.00313	CcSEcCtD
Etravirine—Nervous system disorder—Irinotecan—colon cancer	0.000394	0.00312	CcSEcCtD
Etravirine—Thrombocytopenia—Irinotecan—colon cancer	0.000393	0.00311	CcSEcCtD
Etravirine—Anorexia—Vincristine—colon cancer	0.000393	0.00311	CcSEcCtD
Etravirine—Hyperhidrosis—Irinotecan—colon cancer	0.000388	0.00307	CcSEcCtD
Etravirine—Confusional state—Fluorouracil—colon cancer	0.000388	0.00307	CcSEcCtD
Etravirine—ABCB1—liver—colon cancer	0.000384	0.00448	CbGeAlD
Etravirine—Anorexia—Irinotecan—colon cancer	0.000383	0.00303	CcSEcCtD
Etravirine—Infection—Fluorouracil—colon cancer	0.000382	0.00303	CcSEcCtD
Etravirine—Hepatitis—Capecitabine—colon cancer	0.000378	0.003	CcSEcCtD
Etravirine—Nervous system disorder—Fluorouracil—colon cancer	0.000377	0.00299	CcSEcCtD
Etravirine—Thrombocytopenia—Fluorouracil—colon cancer	0.000376	0.00298	CcSEcCtD
Etravirine—Hypoaesthesia—Capecitabine—colon cancer	0.000376	0.00298	CcSEcCtD
Etravirine—Urinary tract disorder—Capecitabine—colon cancer	0.000373	0.00296	CcSEcCtD
Etravirine—Insomnia—Vincristine—colon cancer	0.000373	0.00295	CcSEcCtD
Etravirine—Connective tissue disorder—Capecitabine—colon cancer	0.000372	0.00294	CcSEcCtD
Etravirine—Urethral disorder—Capecitabine—colon cancer	0.000371	0.00294	CcSEcCtD
Etravirine—Paraesthesia—Vincristine—colon cancer	0.00037	0.00293	CcSEcCtD
Etravirine—Breast disorder—Methotrexate—colon cancer	0.000368	0.00291	CcSEcCtD
Etravirine—Anorexia—Fluorouracil—colon cancer	0.000366	0.0029	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000366	0.0029	CcSEcCtD
Etravirine—Insomnia—Irinotecan—colon cancer	0.000363	0.00288	CcSEcCtD
Etravirine—Paraesthesia—Irinotecan—colon cancer	0.00036	0.00286	CcSEcCtD
Etravirine—Decreased appetite—Vincristine—colon cancer	0.000358	0.00284	CcSEcCtD
Etravirine—Erythema multiforme—Capecitabine—colon cancer	0.000358	0.00283	CcSEcCtD
Etravirine—Somnolence—Irinotecan—colon cancer	0.000357	0.00283	CcSEcCtD
Etravirine—Gastrointestinal disorder—Vincristine—colon cancer	0.000356	0.00282	CcSEcCtD
Etravirine—Fatigue—Vincristine—colon cancer	0.000355	0.00282	CcSEcCtD
Etravirine—Eye disorder—Capecitabine—colon cancer	0.000353	0.0028	CcSEcCtD
Etravirine—Pain—Vincristine—colon cancer	0.000352	0.00279	CcSEcCtD
Etravirine—Constipation—Vincristine—colon cancer	0.000352	0.00279	CcSEcCtD
Etravirine—Cardiac disorder—Capecitabine—colon cancer	0.000351	0.00278	CcSEcCtD
Etravirine—Decreased appetite—Irinotecan—colon cancer	0.000349	0.00276	CcSEcCtD
Etravirine—Eosinophilia—Methotrexate—colon cancer	0.000348	0.00276	CcSEcCtD
Etravirine—Insomnia—Fluorouracil—colon cancer	0.000348	0.00276	CcSEcCtD
Etravirine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000347	0.00275	CcSEcCtD
Etravirine—Fatigue—Irinotecan—colon cancer	0.000346	0.00274	CcSEcCtD
Etravirine—Paraesthesia—Fluorouracil—colon cancer	0.000345	0.00274	CcSEcCtD
Etravirine—Pancreatitis—Methotrexate—colon cancer	0.000345	0.00273	CcSEcCtD
Etravirine—Constipation—Irinotecan—colon cancer	0.000343	0.00272	CcSEcCtD
Etravirine—Pain—Irinotecan—colon cancer	0.000343	0.00272	CcSEcCtD
Etravirine—Angiopathy—Capecitabine—colon cancer	0.000343	0.00272	CcSEcCtD
Etravirine—Somnolence—Fluorouracil—colon cancer	0.000342	0.00271	CcSEcCtD
Etravirine—Immune system disorder—Capecitabine—colon cancer	0.000342	0.00271	CcSEcCtD
Etravirine—Mediastinal disorder—Capecitabine—colon cancer	0.000341	0.0027	CcSEcCtD
Etravirine—Gastrointestinal pain—Vincristine—colon cancer	0.000337	0.00267	CcSEcCtD
Etravirine—Decreased appetite—Fluorouracil—colon cancer	0.000334	0.00265	CcSEcCtD
Etravirine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000332	0.00263	CcSEcCtD
Etravirine—Mental disorder—Capecitabine—colon cancer	0.000331	0.00262	CcSEcCtD
Etravirine—Feeling abnormal—Irinotecan—colon cancer	0.000331	0.00262	CcSEcCtD
Etravirine—Malnutrition—Capecitabine—colon cancer	0.000329	0.00261	CcSEcCtD
Etravirine—Pain—Fluorouracil—colon cancer	0.000329	0.0026	CcSEcCtD
Etravirine—Gastrointestinal pain—Irinotecan—colon cancer	0.000328	0.0026	CcSEcCtD
Etravirine—Abdominal pain—Vincristine—colon cancer	0.000326	0.00258	CcSEcCtD
Etravirine—Body temperature increased—Vincristine—colon cancer	0.000326	0.00258	CcSEcCtD
Etravirine—Flatulence—Capecitabine—colon cancer	0.000324	0.00257	CcSEcCtD
Etravirine—Abdominal pain—Irinotecan—colon cancer	0.000317	0.00251	CcSEcCtD
Etravirine—Body temperature increased—Irinotecan—colon cancer	0.000317	0.00251	CcSEcCtD
Etravirine—Feeling abnormal—Fluorouracil—colon cancer	0.000317	0.00251	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000311	0.00246	CcSEcCtD
Etravirine—Vision blurred—Capecitabine—colon cancer	0.00031	0.00246	CcSEcCtD
Etravirine—Tremor—Capecitabine—colon cancer	0.000308	0.00244	CcSEcCtD
Etravirine—Renal failure—Methotrexate—colon cancer	0.000308	0.00244	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—colon cancer	0.000306	0.00242	CcSEcCtD
Etravirine—Ill-defined disorder—Capecitabine—colon cancer	0.000305	0.00242	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—colon cancer	0.000305	0.00242	CcSEcCtD
Etravirine—Anaemia—Capecitabine—colon cancer	0.000304	0.00241	CcSEcCtD
Etravirine—Body temperature increased—Fluorouracil—colon cancer	0.000304	0.00241	CcSEcCtD
Etravirine—Hypersensitivity—Vincristine—colon cancer	0.000304	0.00241	CcSEcCtD
Etravirine—Malaise—Capecitabine—colon cancer	0.000297	0.00235	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—colon cancer	0.000297	0.00235	CcSEcCtD
Etravirine—Vertigo—Capecitabine—colon cancer	0.000296	0.00234	CcSEcCtD
Etravirine—Hypersensitivity—Irinotecan—colon cancer	0.000296	0.00234	CcSEcCtD
Etravirine—Asthenia—Vincristine—colon cancer	0.000296	0.00234	CcSEcCtD
Etravirine—Syncope—Capecitabine—colon cancer	0.000295	0.00234	CcSEcCtD
Etravirine—ABCB1—lymph node—colon cancer	0.000294	0.00343	CbGeAlD
Etravirine—Loss of consciousness—Capecitabine—colon cancer	0.000289	0.00229	CcSEcCtD
Etravirine—Asthenia—Irinotecan—colon cancer	0.000288	0.00228	CcSEcCtD
Etravirine—Hypertension—Capecitabine—colon cancer	0.000284	0.00225	CcSEcCtD
Etravirine—Hypersensitivity—Fluorouracil—colon cancer	0.000283	0.00224	CcSEcCtD
Etravirine—Diarrhoea—Vincristine—colon cancer	0.000282	0.00223	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—colon cancer	0.000282	0.00223	CcSEcCtD
Etravirine—Anxiety—Capecitabine—colon cancer	0.000279	0.00221	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000278	0.00221	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—colon cancer	0.000278	0.0022	CcSEcCtD
Etravirine—Discomfort—Capecitabine—colon cancer	0.000277	0.00219	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—colon cancer	0.000276	0.00219	CcSEcCtD
Etravirine—Diarrhoea—Irinotecan—colon cancer	0.000275	0.00218	CcSEcCtD
Etravirine—Dry mouth—Capecitabine—colon cancer	0.000274	0.00217	CcSEcCtD
Etravirine—Dizziness—Vincristine—colon cancer	0.000273	0.00216	CcSEcCtD
Etravirine—Confusional state—Capecitabine—colon cancer	0.000271	0.00215	CcSEcCtD
Etravirine—Infection—Capecitabine—colon cancer	0.000267	0.00211	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—colon cancer	0.000266	0.00211	CcSEcCtD
Etravirine—Dizziness—Irinotecan—colon cancer	0.000265	0.0021	CcSEcCtD
Etravirine—Shock—Capecitabine—colon cancer	0.000264	0.00209	CcSEcCtD
Etravirine—Nervous system disorder—Capecitabine—colon cancer	0.000263	0.00209	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—colon cancer	0.000263	0.00208	CcSEcCtD
Etravirine—Diarrhoea—Fluorouracil—colon cancer	0.000263	0.00208	CcSEcCtD
Etravirine—Thrombocytopenia—Capecitabine—colon cancer	0.000263	0.00208	CcSEcCtD
Etravirine—Vomiting—Vincristine—colon cancer	0.000262	0.00208	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—colon cancer	0.000261	0.00207	CcSEcCtD
Etravirine—Skin disorder—Capecitabine—colon cancer	0.000261	0.00207	CcSEcCtD
Etravirine—Rash—Vincristine—colon cancer	0.00026	0.00206	CcSEcCtD
Etravirine—Hyperhidrosis—Capecitabine—colon cancer	0.00026	0.00206	CcSEcCtD
Etravirine—Dermatitis—Vincristine—colon cancer	0.00026	0.00206	CcSEcCtD
Etravirine—Headache—Vincristine—colon cancer	0.000258	0.00205	CcSEcCtD
Etravirine—Anorexia—Capecitabine—colon cancer	0.000256	0.00203	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—colon cancer	0.000255	0.00202	CcSEcCtD
Etravirine—Vomiting—Irinotecan—colon cancer	0.000255	0.00202	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—colon cancer	0.000254	0.00201	CcSEcCtD
Etravirine—Dizziness—Fluorouracil—colon cancer	0.000254	0.00201	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—colon cancer	0.000254	0.00201	CcSEcCtD
Etravirine—Rash—Irinotecan—colon cancer	0.000253	0.00201	CcSEcCtD
Etravirine—Dermatitis—Irinotecan—colon cancer	0.000253	0.002	CcSEcCtD
Etravirine—Headache—Irinotecan—colon cancer	0.000251	0.00199	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—colon cancer	0.000247	0.00195	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—colon cancer	0.000245	0.00194	CcSEcCtD
Etravirine—Nausea—Vincristine—colon cancer	0.000245	0.00194	CcSEcCtD
Etravirine—Vomiting—Fluorouracil—colon cancer	0.000244	0.00194	CcSEcCtD
Etravirine—Insomnia—Capecitabine—colon cancer	0.000243	0.00193	CcSEcCtD
Etravirine—Rash—Fluorouracil—colon cancer	0.000242	0.00192	CcSEcCtD
Etravirine—Dermatitis—Fluorouracil—colon cancer	0.000242	0.00192	CcSEcCtD
Etravirine—Paraesthesia—Capecitabine—colon cancer	0.000241	0.00191	CcSEcCtD
Etravirine—Headache—Fluorouracil—colon cancer	0.000241	0.00191	CcSEcCtD
Etravirine—Nausea—Irinotecan—colon cancer	0.000238	0.00189	CcSEcCtD
Etravirine—Decreased appetite—Capecitabine—colon cancer	0.000234	0.00185	CcSEcCtD
Etravirine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000232	0.00184	CcSEcCtD
Etravirine—Fatigue—Capecitabine—colon cancer	0.000232	0.00184	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—colon cancer	0.000231	0.00183	CcSEcCtD
Etravirine—Constipation—Capecitabine—colon cancer	0.00023	0.00182	CcSEcCtD
Etravirine—Pain—Capecitabine—colon cancer	0.00023	0.00182	CcSEcCtD
Etravirine—Nausea—Fluorouracil—colon cancer	0.000228	0.00181	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—colon cancer	0.000227	0.0018	CcSEcCtD
Etravirine—Anaemia—Methotrexate—colon cancer	0.000227	0.00179	CcSEcCtD
Etravirine—Feeling abnormal—Capecitabine—colon cancer	0.000221	0.00175	CcSEcCtD
Etravirine—Malaise—Methotrexate—colon cancer	0.000221	0.00175	CcSEcCtD
Etravirine—Vertigo—Methotrexate—colon cancer	0.00022	0.00174	CcSEcCtD
Etravirine—Gastrointestinal pain—Capecitabine—colon cancer	0.00022	0.00174	CcSEcCtD
Etravirine—Abdominal pain—Capecitabine—colon cancer	0.000212	0.00168	CcSEcCtD
Etravirine—Body temperature increased—Capecitabine—colon cancer	0.000212	0.00168	CcSEcCtD
Etravirine—Convulsion—Methotrexate—colon cancer	0.000212	0.00168	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000207	0.00164	CcSEcCtD
Etravirine—Discomfort—Methotrexate—colon cancer	0.000206	0.00163	CcSEcCtD
Etravirine—Confusional state—Methotrexate—colon cancer	0.000202	0.0016	CcSEcCtD
Etravirine—Infection—Methotrexate—colon cancer	0.000199	0.00157	CcSEcCtD
Etravirine—Hypersensitivity—Capecitabine—colon cancer	0.000198	0.00157	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—colon cancer	0.000196	0.00155	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—colon cancer	0.000196	0.00155	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—colon cancer	0.000194	0.00154	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—colon cancer	0.000193	0.00153	CcSEcCtD
Etravirine—Asthenia—Capecitabine—colon cancer	0.000193	0.00153	CcSEcCtD
Etravirine—Anorexia—Methotrexate—colon cancer	0.000191	0.00151	CcSEcCtD
Etravirine—Diarrhoea—Capecitabine—colon cancer	0.000184	0.00146	CcSEcCtD
Etravirine—Insomnia—Methotrexate—colon cancer	0.000181	0.00143	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—colon cancer	0.00018	0.00142	CcSEcCtD
Etravirine—Somnolence—Methotrexate—colon cancer	0.000178	0.00141	CcSEcCtD
Etravirine—Dizziness—Capecitabine—colon cancer	0.000178	0.00141	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—colon cancer	0.000174	0.00138	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000173	0.00137	CcSEcCtD
Etravirine—Fatigue—Methotrexate—colon cancer	0.000172	0.00137	CcSEcCtD
Etravirine—Pain—Methotrexate—colon cancer	0.000171	0.00136	CcSEcCtD
Etravirine—Vomiting—Capecitabine—colon cancer	0.000171	0.00135	CcSEcCtD
Etravirine—Rash—Capecitabine—colon cancer	0.000169	0.00134	CcSEcCtD
Etravirine—Dermatitis—Capecitabine—colon cancer	0.000169	0.00134	CcSEcCtD
Etravirine—Headache—Capecitabine—colon cancer	0.000168	0.00133	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—colon cancer	0.000165	0.00131	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—colon cancer	0.000164	0.0013	CcSEcCtD
Etravirine—Nausea—Capecitabine—colon cancer	0.00016	0.00126	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—colon cancer	0.000158	0.00125	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—colon cancer	0.000158	0.00125	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—colon cancer	0.000147	0.00117	CcSEcCtD
Etravirine—Asthenia—Methotrexate—colon cancer	0.000143	0.00114	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—colon cancer	0.000137	0.00108	CcSEcCtD
Etravirine—Dizziness—Methotrexate—colon cancer	0.000132	0.00105	CcSEcCtD
Etravirine—Vomiting—Methotrexate—colon cancer	0.000127	0.00101	CcSEcCtD
Etravirine—Rash—Methotrexate—colon cancer	0.000126	0.000999	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—colon cancer	0.000126	0.000998	CcSEcCtD
Etravirine—Headache—Methotrexate—colon cancer	0.000125	0.000993	CcSEcCtD
Etravirine—Nausea—Methotrexate—colon cancer	0.000119	0.000941	CcSEcCtD
